Assenagon Asset Management S.A. Boosts Stock Position in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)
Assenagon Asset Management S.A. increased its stake in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 211.7% in the first quarter, HoldingsChannel reports. The firm owned 215,890 shares of the biopharmaceutical company’s stock after buying an additional 146,617 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Ultragenyx Pharmaceutical were worth $7,817,000 […]
